A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

Clinical trial NCT06544330 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06544330
Sponsor: Synthekine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Lupus Nephritis Systemic Sclerosis

Start date: 2025-04-29
Primary completion: 2028-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.